Trial intelligence / Profile preview

Mozobil and G-CSF for stem cell mobilization in lymphoma

NCT01164345Phase 2Completed

Sponsor
Sheba Medical Center
Start
Jun 2010
Primary completion
May 2015
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of plerixafor in non-Hodgkin lymphoma (NHL), Hodgkin lymphoma (HL), sponsored by Sheba Medical Center. Started Jun 2010; status: completed.

02

Drugs

plerixafor
03

Conditions

non-Hodgkin lymphoma (NHL)Hodgkin lymphoma (HL)

Beyond the preview

Go deeper on NCT01164345.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01164345.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call